Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Senthamil R. Selvan"'
Autor:
Mepur H. Ravindranath, Narendranath M. Ravindranath, Senthamil R. Selvan, Fatiha El Hilali, Carly J. Amato-Menker, Edward J. Filippone
Publikováno v:
Biomolecules, Vol 13, Iss 8, p 1178 (2023)
Cell surface HLA-I molecules (Face-1) consist of a polypeptide heavy chain (HC) with two groove domains (G domain) and one constant domain (C-domain) as well as a light chain, B2-microglobulin (B2m). However, HCs can also independently emerge unfolde
Externí odkaz:
https://doaj.org/article/0bdda8efb484481b832af4b6676d5c6a
Autor:
Mepur H. Ravindranath, Narendranath M. Ravindranath, Carly J. Amato-Menker, Fatiha El Hilali, Senthamil R. Selvan, Edward J. Filippone, Luis Eduardo Morales-Buenrostro
Publikováno v:
Antibodies, Vol 12, Iss 2, p 26 (2023)
Rheumatoid arthritis (RA) is a progressive, inflammatory, autoimmune, symmetrical polyarticular arthritis. It is characterized by synovial infiltration and activation of several types of immune cells, culminating in their apoptosis and antibody gener
Externí odkaz:
https://doaj.org/article/a5f8e98eb9814c169beb6628a9c6e688
Autor:
Mepur H. Ravindranath, Fatiha El Hilali, Carly J. Amato-Menker, Hajar El Hilali, Senthamil R. Selvan, Edward J. Filippone
Publikováno v:
Antibodies, Vol 11, Iss 3, p 58 (2022)
Cell-surface HLA-I molecules consisting of β2-microglobulin (β2m) associated heavy chains (HCs), referred to as Face-1, primarily present peptides to CD8+ T-cells. HCs consist of three α-domains, with selected amino acid sequences shared by all al
Externí odkaz:
https://doaj.org/article/e55fe62b87ca4ea286fcec34d58afc1e
Autor:
Mepur H. Ravindranath, Narendranath M. Ravindranath, Fatiha El Hilali, Senthamil R. Selvan, Edward J. Filippone
Publikováno v:
Antibodies, Vol 11, Iss 1, p 18 (2022)
Serum anti-HLA-I IgG are present in non-alloimmunized males, cancer patients, and transplant recipients. Anti-HLA-I antibodies are also present in intravenous immunoglobulin (IVIg), prepared from the plasma of thousands of healthy donors. However, th
Externí odkaz:
https://doaj.org/article/41d60baef0024a7ebc2dfee16fcfd8c2
Autor:
Kavita Dhodapkar, Brent A Hanks, Holden T Maecker, Siwen Hu-Lieskovan, Sumati Gupta, Yoshinobu Koguchi, Srabani Bhaumik, Cristina Maccalli, Sylvia Janetzki, Yingdong Zhao, Jean-Charles J B Grivel, Thomas O Kleen, Amanda W Lund, Yolanda D Mahnke, Ruslan D Novosiadly, Senthamil R Selvan, Tasha Sims
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Since the publication of the Society for Immunotherapy of Cancer’s (SITC) original cancer immunotherapy biomarkers resource document, there have been remarkable breakthroughs in cancer immunotherapy, in particular the development and approval of im
Externí odkaz:
https://doaj.org/article/15ac320dfb9843698d79bbf6c3576138
Autor:
Mepur H. Ravindranath, Narendranath M. Ravindranath, Senthamil R. Selvan, Edward J. Filippone, Carly J. Amato-Menker, Fatiha El Hilali
Publikováno v:
Vaccines, Vol 10, Iss 2, p 339 (2022)
Leukocyte cell-surface HLA-I molecules, involved in antigen presentation of peptides to CD8+ T-cells, consist of a heavy chain (HC) non-covalently linked to β2-microglobulin (β2m) (Face-1). The HC amino acid composition varies across all six isofor
Externí odkaz:
https://doaj.org/article/51b17fce020445aaab6e33f8ba8e4abc
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Externí odkaz:
https://doaj.org/article/694a8a5a595946cbb6b24249340ac00d
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
Externí odkaz:
https://doaj.org/article/3096da30bcb34a95999935e438c7d428
Autor:
Jenny Zhang, Alessandra Cesano, Lisa H. Butterfield, Giuseppe V. Masucci, Rachael Hawtin, Ilan Kirsch, Sylvia Janetzki, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Magdalena Thurin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
There is growing recognition that immunotherapy is likely to significantly improve health outcomes for cancer patients in the coming years. Currently, while a subset of patients experience substantial clinical benefit in response to different immunot
Externí odkaz:
https://doaj.org/article/748ae8e988824512bc03a5774ee55e31
Autor:
Jenny Zhang, Alessandra Cesano, Lisa H. Butterfield, Giuseppe V. Masucci, Rachael Hawtin, Ilan Kirsch, Sylvia Janetzki, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Magdalena Thurin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
Immunotherapies have emerged as one of the most promising approaches to treat patients with cancer. Recently, there have been many clinical successes using checkpoint receptor blockade, including T cell inhibitory receptors such as cytotoxic T-lympho
Externí odkaz:
https://doaj.org/article/4a82936ee76d4634b39c83d24e2dece9